Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/17/14  and contains information from public web pages and contributions from the ZoomInfo community.

Ms. Nancy S. Lurker

Wrong Nancy S. Lurker?
 
Background

Employment History

Board Memberships and Affiliations

Education

  • M.B.A.
    University of Evansville
  • B.S. , Biology
    Seattle Pacific University
  • BS , biology and chemistry
    Seattle Pacific University
  • MBA
    University of Evansville
  • B.S. , Biology and Chemistry
    Seattle Pacific University
172 Total References
Web References
"The launch of ThyGenX represents the ...
www.dddmag.com, 17 Dec 2014 [cached]
"The launch of ThyGenX represents the next step in building Interpace Diagnostics' emerging endocrine cancer test franchise," said Nancy Lurker, CEO of PDI, Inc.
Board of Directors
www.auxilium.com, 29 May 2014 [cached]
Nancy Lurker has served as one of our directors since June 2011. She has served as Chief Executive Officer and a director of PDI, Inc. since November 2008. Prior to joining PDI, Ms. Lurker was Senior Vice President and Chief Marketing Officer of Novartis Pharmaceuticals Corporation, the US subsidiary of Novartis AG, where she oversaw a product portfolio in multiple therapeutic areas from June 2006 to December 2007. Prior to that, she served as President and Chief Executive Officer of ImpactRx, Inc. since 2003. From 2000 to 2003, Ms. Lurker served as Group Vice President-Global Primary Care Products for Pharmacia Corporation and as Global and US Vice-President for Detrol from 1998-2000 at Pharmacia. From 1984 to 1998, Ms. Lurker rose from senior sales representative at Bristol Myer Squibb to various product management and business development positions, ultimately becoming Senior Director-Worldwide Cardiovascular Franchise Management of Bristol-Myers Squibb. Ms. Lurker was a director of Elan Pharmaceuticals during 2005 and 2006 and of ConjuChem Biotechnologies Inc. from 2004 to 2006. Ms. Lurker received a BS in Biology with high honors from Seattle Pacific University and an MBA from the University of Evansville. Ms. Lurker's more than 25 years of experience in the life sciences industry brings valuable commercial, operations and general management experience to the Board. In addition, her experience as a director of other publicly held life sciences companies brings further oversight and corporate governance experience to the Board.
DUBLIN, Ireland--(BUSINESS WIRE)--May 18, ...
ir.elan.com [cached]
DUBLIN, Ireland--(BUSINESS WIRE)--May 18, 2006--Elan Corporation, plc ("Elan") today announces the resignation of Nancy Lurker as a non-executive director of the Company with effect from May 31, 2006. Ms Lurker has been a director of Elan since May 2005. Ms Lurker this week announced that she will be taking up the position of Chief Marketing Officer, Novartis Pharmaceuticals, US.
Nancy Lurker Ms. ...
phx.corporate-ir.net, 18 Aug 2014 [cached]
Nancy Lurker Ms. Lurker joined us as Chief Executive Officer and a director in November 2008. Prior to joining PDI, Ms. Lurker was senior vice-president and chief marketing officer for Novartis Pharmaceuticals Corporation, the U.S. subsidiary of Novartis AG, where she oversaw a product portfolio in multiple therapeutic areas from 2006 to 2007. Prior to that, she was president and chief executive officer of ImpactRx, Inc. since 2003, a privately owned company offering among its services the evaluation of the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest prescribing physicians. From 2000 to 2003, Ms. Lurker served as group vice president-global primary care products for Pharmacia Corporation, where she led a business unit that commercialized drugs for urology, cardiovascular, central nervous system, respiratory and women's health. She was also a member of Pharmacia's U.S. executive management committee, the group responsible for managing all U.S.-based profits as well as all U.S. management policies. Earlier in her career, she was vice president for business development at National Physicians Corporation, an IPA risk management and practice management group. During her 14 years at Bristol-Myers Squibb, Ms. Lurker rose from senior sales representative at Mead Johnson to various product management and business development positions, ultimately becoming senior director-worldwide cardiovascular franchise management. Ms. Lurker received a B.S. in Biology with high honors from Seattle Pacific University and an M.B.A. from the University of Evansville in Evansville, Indiana.
inVentiv Health - About Us - Newsroom - Press Releases
www.ventive.com, 1 July 2005 [cached]
Nancy Lurker, Chief Executive Office, ImpactRx
Other People with the name "Lurker":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304